This week’s episode

Nvidia agrees to buy Hugging | 🧪 In-body CAR-T eases MS | WeatherNext 3 refreshes hourly at | 🧬 Two psilocybin doses block chemo | FDA clears Zanvastro as first | 🤖 Allen Institute opens AI BioDesign

Sep '26 – This week brings transformative advances across AI-driven medicine and computing. From Nvidia's landmark acquisition of Hugging Face to FDA approval of the first Alexander disease treatment and promising early results.

Ready to play4 Sept 2026

The audio edition

This week's NotebookLM episode

00:00--:--

Article stream

Selected articles, synthesized in order

Reuters2 min read

Nvidia agrees to buy Hugging Face for $12.93B

Nvidia and Hugging Face signed a definitive agreement on September 2, 2026, for a deal worth about $12.93 billion: roughly $11.9 billion to stockholders plus up to about $1 billion in equity retention. Nvidia says Hugging Face will remain an open platform for the AI ecosystem. Closing is expected in the first half of 2027, pending regulators, and an SEC 8-K confirms the terms.

Read source

Nature2 min read

In-body CAR-T eases MS in 16-person NEJM trial

A Nature report on a New England Journal of Medicine trial describes 16 people with multiple sclerosis or other autoimmune conditions who received a lentivirus that delivers CAR instructions inside the body. The engineered T cells target autoantibodies on B cells. Over about six months of follow-up, motor, cognitive, and fatigue measures improved in MS patients, though the authors call the results promising, not definitive.

Read source

Google DeepMind2 min read

WeatherNext 3 refreshes hourly at 5 km resolution

Google DeepMind and Google Research released WeatherNext 3 on September 3 with hourly refreshes and real-time geostationary satellite inputs. Surface variables now run at 5 km, down from a prior 25 km / 6-hour cadence, and precipitation CRPS improved by up to 60 percent versus IMERG, with Brightband live evals cited. The model is rolling into Search, Gemini, Maps, and Cloud.

Read source

Nature2 min read

Two psilocybin doses block chemo neuropathy in mice

A Nature write-up of a Science paper reports that two psilocybin doses given before chemotherapy prevented neuropathy in mice. Platinum chemo neuropathy affects about 60 percent of patients; the treated mice kept paw sensation and nerve endings without cutting how much tumors shrank. Non-hallucinogenic tabernanthalog also worked through the same receptors.

Read source

FDA2 min read

FDA clears Zanvastro as first Alexander disease drug

On September 3, 2026, the FDA approved Zanvastro (zilganersen), an Ionis antisense drug against GFAP and the first approved treatment for Alexander disease. It is given as an intrathecal injection every three months. In trial NCT04849741 (49 patients ages 2 and older, plus four under 2), patients ages 5 and older walked faster at 61 weeks.

Read source

Allen Institute2 min read

Allen Institute opens AI BioDesign accelerator with UW

The Allen Institute, University of Washington, and Fred Hutch, with Fund for Science and Technology support, announced AI BioDesign on September 3. The accelerator will publish open models, datasets, and tools on a design-build-measure-learn loop. David Baker and Jay Shendure serve as scientific directors.

Read source

Markets

Trending stocks and pre-market pulse

Current extended-hours prices plus the plain-English reason each ticker is moving.

Fri, Sep 4, 4:21 AM EDT

S&P 500 Futures$7,759.50regular · +0.06%

regular · prior market settlement · 4:11 AM EDT

Nasdaq 100 Futures$29,663regular · +0.47%

regular · prior market settlement · 4:11 AM EDT

Dow Futures$53,696regular · -0.09%

regular · prior market settlement · 4:11 AM EDT

Gold$4,527.20-0.28%regular · prior market settlement · 4:11 AM EDT

Bitcoin$80,846+3.85%regular · rolling 24 hours · 4:19 AM EDT

LULUpre marketpre market · previous regular close · 4:06 AM EDT

-17.58%

Lululemon shares plummeted as the company reported a decline in quarterly revenue and same-store sales, exacerbated by significantly lowered full-year guidance and weak demand in core markets. While some traders view the resulting price drop as a potential buying opportunity for a long-term turnarou

PLpre marketpre market · previous regular close · 4:06 AM EDT

+9.05%

Planet Labs shares received attention following a second-quarter report that featured a revenue and earnings beat, though some traders expressed concern over weaker third-quarter guidance and the impact of contract timing on results. Despite the softer outlook, community sentiment remains notably bu

PATHpre marketpre market · previous regular close · 4:06 AM EDT

-9.30%

UiPath shares experienced significant volatility following a second-quarter report that featured a revenue beat and raised full-year guidance but also showed narrowing gross margins. While some traders focused on the potential for an 'agentic AI' breakout, others expressed disappointment with the gr

04 — Internet: For You

What’s buzzing online right now

X · Hacker News · Tech press

Taalas chip demo ~14k tokens/sec Emad Mostaque shows a Taalas chip running Chat Jimmy at roughly 14,000 tokens per second; AMD acquired Taalas in August 2026.

Taalas / Emad Mostaque

View this post on Instagram

Open original

GPT-6 Astra computer-agent demo OpenAI’s Astra demo moves across apps—Blender to a playable 3D game, docs, bookings—acting as a full computer agent rather than chat-only.

GPT-6 Astra

View this post on Instagram

Open original

Previous episodes

Recent briefings you may have missed

View all

Wed, Sep 2, 2026WedPrecision medicine and AI: new paths to diagnosis
Mon, Jul 20, 2026MonInfrastructure Leaps and Biological Breakthroughs Transform Medicine and Technology
Fri, Jun 26, 2026FriThe Precision Revolution: From Atoms to Genomes, Control Becomes the New Frontier
Wed, Jun 24, 2026WedFrom Lab to Life: AI and Materials Science Reshape Medicine, Energy, and Manufacturing
Mon, Jun 22, 2026MonAI Ambitions Meet Open Alternatives as Immune Breakthroughs Reshape Medicine
Wed, Jun 17, 2026WedSmarter AI, Sharper Diagnostics, and Signals from Markets and the Web
Mon, Jun 8, 2026MonAI labs sound a biosecurity alarm. A cheaper path to clean hydrogen. Tesla jumps as the Nasdaq leads.
Tue, Mar 31, 2026Tue🧠 Thought-to-Speech Revolution | 🎮 Brain-Controlled Gaming | 🧬 Anti-Aging Immune Boost
Archived
Fri, Aug 29, 2025Fri🏫 The AI Hogwarts | 💉 Drug Discovery
Archived
Wed, Aug 6, 2025Wed🔋 AI Battery Breakthrough | 🩸 Longevity Secrets | 💊 HIV | 🇨🇳 China's Drug Discovery Race | 🌐 DeepMind's Genie-3 | 🤖 OpenAI Opens Up
Archived

Nvidia agrees to buy Hugging | 🧪 In-body CAR-T eases MS | WeatherNext 3 refreshes hourly at | 🧬 Two psilocybin doses block chemo | FDA clears Zanvastro as first | 🤖 Allen Institute opens AI BioDesign

Selected articles, synthesized in order

Nvidia agrees to buy Hugging Face for $12.93B

In-body CAR-T eases MS in 16-person NEJM trial

WeatherNext 3 refreshes hourly at 5 km resolution

Two psilocybin doses block chemo neuropathy in mice

FDA clears Zanvastro as first Alexander disease drug

Allen Institute opens AI BioDesign accelerator with UW

What’s buzzing online right now

Recent briefings you may have missed

Stay ahead of the curve.Three times a week.

Stay ahead of the curve.
Three times a week.